Xiaoming Wen

4.4k total citations · 2 hit papers
26 papers, 2.4k citations indexed

About

Xiaoming Wen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoming Wen has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Xiaoming Wen's work include Immune Response and Inflammation (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Epigenetics and DNA Methylation (3 papers). Xiaoming Wen is often cited by papers focused on Immune Response and Inflammation (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Epigenetics and DNA Methylation (3 papers). Xiaoming Wen collaborates with scholars based in United States, China and Japan. Xiaoming Wen's co-authors include Gary D. Wu, Mitchell A. Lazar, Wen G. Jiang, Sue A. Keilbaugh, Sreekant Murthy, Chinyu Su, Anne Flanigan, Shannon T. Bailey, Shamina M. Rangwala and Ning Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Xiaoming Wen

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response

1999 665 citations Chinyu Su, Xiaoming Wen et al. Journal of Clinical Investigation profile →
A family of tissue-specific resistin-like molecules

2001 531 citations Debra G. Silberg, Xiaoming Wen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoming Wen United States	16	1.1k	571	494	455	451	26	2.4k
Jian Wu China	30	1.5k 1.3×	393 0.7×	354 0.7×	229 0.5×	338 0.7×	118	3.0k
Yup Kang South Korea	30	1.3k 1.2×	962 1.7×	537 1.1×	375 0.8×	490 1.1×	99	3.5k
Vincent Braunersreuther Switzerland	28	750 0.7×	582 1.0×	256 0.5×	467 1.0×	955 2.1×	43	2.7k
Bhavapriya Vaitheesvaran United States	17	1.2k 1.1×	575 1.0×	598 1.2×	246 0.5×	190 0.4×	20	2.3k
Eek Joong Park United States	13	1.4k 1.2×	1.1k 1.9×	333 0.7×	413 0.9×	458 1.0×	13	2.9k
Nicholas F. Brown United States	29	2.3k 2.0×	587 1.0×	1.1k 2.2×	353 0.8×	300 0.7×	60	3.9k
Katrin Düvel United States	9	1.9k 1.6×	398 0.7×	385 0.8×	211 0.5×	316 0.7×	12	2.7k
Shinji Mizuarai Japan	16	1.1k 1.0×	621 1.1×	461 0.9×	616 1.4×	293 0.6×	30	2.2k
Fan Yeung United States	15	1.6k 1.4×	637 1.1×	715 1.4×	668 1.5×	391 0.9×	21	3.6k
Hueng-Sik Choi South Korea	31	1.5k 1.3×	397 0.7×	296 0.6×	406 0.9×	266 0.6×	56	2.8k

Countries citing papers authored by Xiaoming Wen

Since Specialization

Citations

This map shows the geographic impact of Xiaoming Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Wen more than expected).

Fields of papers citing papers by Xiaoming Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Wen. The network helps show where Xiaoming Wen may publish in the future.

Co-authorship network of co-authors of Xiaoming Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Wen. A scholar is included among the top collaborators of Xiaoming Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Wen. Xiaoming Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaorui, et al.. (2021). [Altered dopamine metabolism and its role in pathogenesis of Parkinson's disease].. 73(1). 89–102. 2 indexed citations

Li, Qijun, et al.. (2021). Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells. Neurochemical Research. 46(6). 1502–1513. 9 indexed citations

Mansfield, Aaron S., Andrzej Każarnowicz, Nina Karaseva, et al.. (2020). Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial. Annals of Oncology. 31(2). 310–317. 126 indexed citations

Guo, Chang‐Ying, et al.. (2019). The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. BMC Cancer. 19(1). 289–289. 24 indexed citations

Chen, Bingbing, Xiaoming Wen, Hong Jiang, et al.. (2019). Interactions between iron and α-synuclein pathology in Parkinson's disease. Free Radical Biology and Medicine. 141. 253–260. 76 indexed citations

Stubbs, Matthew C., Xiaoming Wen, Chu‐Biao Xue, et al.. (2018). Abstract 2938: In vivo assessment of the combination of the JAK1 selective inhibitor itacitinib with first- and second-generation EGFR inhibitors in models of non-small cell lung cancer. Cancer Research. 78(13_Supplement). 2938–2938. 3 indexed citations

Guo, Chang‐Ying, Yan Chen, Lan Luo, et al.. (2017). Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells. Oncology Reports. 37(4). 2161–2166. 16 indexed citations

Ruggeri, Bruce, Matthew C. Stubbs, Ashish Juvekar, et al.. (2017). Abstract 1234: The novel FGFR4-selective inhibitor INCB062079 is efficacious in models of hepatocellular carcinoma harboring FGF19 amplification. Cancer Research. 77(13_Supplement). 1234–1234. 6 indexed citations

Liu, Xuesong, Jun Li, Xin He, et al.. (2015). Abstract 3525: The BET inhibitor INCB054329 is efficacious as a single agent or in combination with targeted agents in colorectal cancer models. Cancer Research. 75(15_Supplement). 3525–3525. 1 indexed citations

10.

Stubbs, Matthew C., Xiaoming Wen, Eian Caulder, et al.. (2015). Abstract 691: Activity of the BET inhibitor INCB054329 in models of multiple myeloma. Cancer Research. 75(15_Supplement). 691–691. 1 indexed citations

11.

Dai, Lu, Yuqing Liu, Junyang Liu, et al.. (2013). A novel CyclinE/CyclinA-CDK Inhibitor targets p27Kip1 degradation, cell cycle progression and cell survival: Implications in cancer therapy. Cancer Letters. 333(1). 103–112. 42 indexed citations

12.

Li, Jun, Margaret Favata, Eian Caulder, et al.. (2010). INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support. Neoplasia. 12(1). 28–38. 62 indexed citations

13.

Fridman, Jordan S., Eian Caulder, Xiaoming Wen, et al.. (2009). Abstract #2848: Small molecule inhibitors of JAK1/2 improve physiological and functional measures of cancer-associated cachexia. Cancer Research. 69. 2848–2848. 1 indexed citations

14.

Alrefai, Waddah A., Xiaoming Wen, Wen G. Jiang, et al.. (2007). Molecular cloning and promoter analysis of downregulated in adenoma (DRA). American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(5). G923–G934. 42 indexed citations

15.

Yu, ZaiFang, Guanjun Cheng, Xiaoming Wen, et al.. (2002). Tumor Necrosis Factor α Increases Neuronal Vulnerability to Excitotoxic Necrosis by Inducing Expression of the AMPA–Glutamate Receptor Subunit GluR1 via an Acid Sphingomyelinase- and NF-κB-Dependent Mechanism. Neurobiology of Disease. 11(1). 199–213. 69 indexed citations

16.

Loring, Jeanne F., et al.. (2001). A Gene Expression Profile of Alzheimer's Disease. DNA and Cell Biology. 20(11). 683–695. 254 indexed citations

17.

Wen, Xiaoming & Gary D. Wu. (2001). Evidence for Epigenetic Mechanisms That Silence Both Basal and Immune-Stimulated Transcription of the IL-8 Gene. The Journal of Immunology. 166(12). 7290–7299. 21 indexed citations

18.

Su, Chinyu, Xiaoming Wen, Shannon T. Bailey, et al.. (1999). A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. Journal of Clinical Investigation. 104(4). 383–389. 665 indexed citations breakdown →

19.

Wu, Gary D., et al.. (1999). High-level expression of IkB-b in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role. Journal of Leukocyte Biology. 66(6). 1049–1056. 33 indexed citations

20.

Jiang, Wen G., Emma E. Furth, Xiaoming Wen, et al.. (1998). Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. American Journal of Physiology-Gastrointestinal and Liver Physiology. 275(6). G1445–G1453. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact